Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Explore Zero-Based Budgeting Tips For Family Finances that tighten budgeting without sacrificing essentials, helping you save more each month.
18,323 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Microsoft has faced a recent pullback, but the company’s cloud, AI, and productivity strengths create a path to meani...
Lawmakers reached an in-principle agreement on stablecoin-yield provisions within the CLARITY Act, a move that could ...
Babcock Wilcox stock surged after a mixed Q1 report that featured a revenue beat but a larger-than-expected earnings ...
A private market deal around a smartphone rewards model is near closing, riding momentum from Deloitte’s fastest-grow...
A billionaire-backed fund is quietly accumulating Robinhood stock even as executives unload shares, a move prompting ...
A Wisconsin investment scheme turned from high hopes to hard lessons. Investors were promised returns, but prosecutor...
Emerging markets can boost growth, but they come with unique risks. This guide explains what to consider before addin...
A CBS Philadelphia anchor became a reminder that scammers exploit trusted voices. Learn how the philadelphia anchor s...
A large investor reportedly exited a sizable MercadoLibre position, triggering headlines about the move. This article...
When a CEO sells a large block of stock, investors take notice. This article breaks down Ingredion's recent insider m...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...